Type 2 diabetes patients who received a duodenal-jejunal liner showed a mean A1C of 7.5% at 52 weeks, compared with 8.6% at baseline, according to a study presented at the European Association for the Study of Diabetes meeting. Researchers also noted significant improvements in fasting glucose, acute glucose response and insulin resistance in patients.

Related Summaries